View Archive | Home | Product News

Powerful Pharmacology Profiling Solution

Aug 08
'After intensive development and customer validation, we are delighted to release AurPROFILER.' said Jason Theodosiou, President and CEO of Aureus Pharma.

Aureus Pharma, a leading provider of knowledge management solutions that accelerate life science discovery, announced the release today of the new software solution AurPROFILER�. AurPROFILER enables researchers to rapidly evaluate target, cell and drug profiles using bio-assays derived from the activity data found in Aureus Pharma's AurSCOPE� Target Knowledge databases.

AurPROFILER has been designed to work in conjunction with the just released AurSCOPE® Global Pharmacology Space and all of Aureus’ drug target focused knowledge databases.

Compound profiling is routinely used by pharmaceutical researchers to evaluate the critical issues of drug target selectivity including off-target effects, polypharmacology and cytotoxicity. With easily interpretable graphics, AurPROFILER provides valuable insights to help better manage these issues by rapidly providing in-silico profiles. AurPROFILER results facilitate better discovery team decision making, and reduce risk to that streamline drug discovery projects. AurPROFILER was developed in collaboration with a pharmaceutical industry focus group consisting of several major pharmaceutical companies.

“After intensive development and customer validation, we are delighted to release AurPROFILER.” said Jason Theodosiou, President and CEO of Aureus Pharma. “AurPROFILER is an example where the combination of Aureus’ analysis capabilities and the high quality data within AurSCOPE Knowledge databases combine to bring additional value to researchers.”

Aureus Pharma experts will demonstrate AurPROFILER at the American Chemical Society (ACS) meeting in Philadelphia, PA August 18th -21st.

About Aureus Pharma
Aureus Pharma headquartered in Paris, France is a privately held knowledge management based solutions provider for the life sciences industry. Aureus Pharma accelerates new drug discovery by providing knowledge databases which contain high quality quantitative information for both chemistry and biology. Researchers gain rapid access to knowledge for important drug target classes including GPCR, Ion Channel, Kinase as well as other critical pharmaceutical topics including ADME/Drug-Drug Interactions and the hERG Channel. The information contained in the Aureus Pharma system is of primary importance to aid in lead discovery and optimization as well as to build predictive models. For further information on how Aureus Pharma helps researchers turn data into discovery visit www.aureus-pharma.com



Media Contact

Mary Donlan
Director of Marketing
Aureus Pharma
Phone: 33 1 40 18 57 59/ 33 6 76 19 51 77
mary.donlan@aureus-pharma.com

 
Related Articles

SEARCH

Advanced